|
Characteristics of the study population |
|||
| ALL n = 9,419 |
MALES n = 4,478† |
FEMALES N = 4,908† |
|
|
|
|||
| Gender (%) |
47.5 |
52.1 |
|
|
|
|||
| Age groups (%) |
|||
| 12 – 44 |
24.5 |
23.1 |
26.0 |
| 45 – 54 |
14.9 |
15.5 |
14.5 |
| 55 – 64 |
18.9 |
21.6 |
16.5 |
| 65 – 74 |
24.6 |
25.6 |
23.7 |
| 75 – 99 |
16.7 |
14.1 |
19.2 |
|
|
|||
| Study populations |
|||
| General population |
40.8 |
38.0 |
43.5 |
| Primary care patients |
7.4 |
4.5 |
10.0 |
| Musculoskeletal system & connective tissue diseases |
9.2 |
5.5 |
12.7 |
| COPD/Asthma |
9.2 |
14.0 |
4.8 |
| Toxic Oil Syndrome |
8.9 |
6.5 |
11.2 |
| Chronic Kidney Failure |
7.6 |
9.4 |
6.0 |
| Cardiovascular diseases |
3.2 |
5.5 |
0.9 |
| Others |
13.8 |
16.6 |
10.9 |
|
† For a subset of individuals (n = 33) information on gender was not available | |||
Prieto et al. Health and Quality of Life Outcomes 2003 1:27 doi:10.1186/1477-7525-1-27 |
|||